Adenine phosphoribosyltransferase
Adenine phosphoribosyltransferase
Adenine phosphoribosyltransferase (APRT) is an enzyme that plays a crucial role in the purine salvage pathway, which is essential for the recycling of purines to synthesize nucleotides. This enzyme catalyzes the conversion of adenine and phosphoribosyl pyrophosphate (PRPP) into adenosine monophosphate (AMP).
Function
APRT is responsible for the salvage of adenine, a purine base, by converting it into AMP. This reaction is important for maintaining the balance of purine nucleotides in the cell and for conserving energy by recycling purines rather than synthesizing them de novo.
Mechanism
The reaction catalyzed by APRT involves the transfer of a phosphoribosyl group from PRPP to adenine, forming AMP and pyrophosphate. This reaction is facilitated by the enzyme's active site, which binds both substrates and stabilizes the transition state.
Structure
APRT is a homodimeric enzyme, meaning it consists of two identical subunits. Each subunit contains a flexible loop and a hood domain that are important for substrate binding and catalysis.
Active Site
The active site of APRT is where adenine and PRPP bind. The enzyme undergoes conformational changes upon substrate binding, which facilitates the catalytic process. The binding site is highly specific for adenine, ensuring the correct substrate is utilized.
Genetic Implications
Mutations in the APRT gene can lead to a deficiency in the enzyme, resulting in the accumulation of adenine and its conversion to 2,8-dihydroxyadenine, which can cause kidney stones and renal failure. This condition is known as APRT deficiency.
Clinical Significance
APRT deficiency is a rare genetic disorder that can lead to the formation of kidney stones composed of 2,8-dihydroxyadenine. Early diagnosis and treatment are important to prevent kidney damage. Treatment typically involves a low-purine diet and medications that reduce adenine production.
Related pages
Gallery
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
